A lesion’s contrast enhancement pattern and change in size after treatment can predict the successful radio-frequency ablation of a lung tumor, according to a study in the October issue of the American Journal of Roentgenology.
A lesion's contrast enhancement pattern and change in size after treatment can predict the successful radio-frequency ablation of a lung tumor, according to a study in the October issue of the American Journal of Roentgenology.
Dr. Gong Yong Jin and colleagues at Chonbuk and Seoul National University Hospitals in Korea retrospectively evaluated 21 patients who underwent percutaneous RFA for lung cancer and metastases from extrapulmonary lesions. Using contrast-enhanced CT, they sought to describe postablation lesion characteristics and patient response to treatment.
The researchers found that the most successfully ablated lesions appeared on follow-up scans as low-attenuation areas without contrast enhancement. These lesions consistently shrank on subsequent follow-up scans.
Based on contrast-enhanced CT findings after treatment, the researchers split patients into two groups: those who had achieved complete ablation, and those with a partial ablation. Follow-up CT imaging of each group showed serial changes in enhancement patterns, size, peripheral ground-glass opacities, and other factors.
Nine patients in the complete ablation group showed no contrast enhancement on follow-up CT. Their lesions' mean reduction rate at three, six, nine, 12, and 15 months compared with the size right after treatment was 5.7%, 11.4%, 14.3%, 40%, and 40%, respectively.
Twelve patients in the partial ablation group showed diverse degrees of enhancement. In contrast to the previous group, their lesions gradually increased in size after the six-month follow-up with CT. Five out of 21 lesions on postablation scans showed enveloped ground-glass opacity surrounding the tumor.
Usually, a brief increase in blood flow occurs along the tissue surrounding an ablated lesion. Experts speculate that residual malignant cells overlapping this area might go undetected by follow-up CT immediately after treatment. Ablation should thus include a peripheral normal tissue margin of .5 to 1 cm to boost results and increase the sensitivity of treatment follow-up.
Lack of histopathologic confirmation limited the study's measure for success. Several other researchers, however, agree that contrast-enhanced CT findings may correlate well with the ablated lesion's pathologic features, the investigators wrote in the study.
For more information from the Diagnostic Imaging archives:
RFA for liver breaks further ground
RF ablation of lung tumors wins support
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.